drugset
Drugs / High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose)
last change Mar 2017 re-read 2 minutes ago

High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose)

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · Stanford University

Trials 1 · a red edge is where a trial was stopped

today NCT01827462 · Ph 4
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01827462 Oct 2007 → Dec 2015 influenza Stanford University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose) ClinicalTrials.gov intervention name — accepted as the source's own label NCT01827462 ↗
Modality Vaccine “High-Dose trivalent, inactivated influenza vaccine (TIV High-Dose) was given.” NCT01827462 ↗
Route Intramuscular “Fluzone High-Dose (IM)” NCT01827462 ↗